{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:22:04Z","timestamp":1793996524108,"version":"4.8.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["CNPq\/MS\/SCTIE\/DECIT No 26\/2014\u2014Pesquisas sobre Dist\u00farbios Neuropsiqui\u00e1tricos; 466805\/2014-4"],"award-info":[{"award-number":["CNPq\/MS\/SCTIE\/DECIT No 26\/2014\u2014Pesquisas sobre Dist\u00farbios Neuropsiqui\u00e1tricos; 466805\/2014-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008353","name":"Funda\u00e7\u00e3o de Apoio ao Ensino, Pesquisa e Assist\u00eancia do Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007762","name":"Instituto Nacional de Ci\u00eancia e Tecnologia Translacional em Medicina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02009","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T10:55:40Z","timestamp":1537527340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":255,"title":["Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age"],"prefix":"10.3389","volume":"9","author":[{"given":"Jos\u00e9 A.","family":"Crippa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alline C.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio W.","family":"Zuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1590\/S1516-44462010000500002","article-title":"Research with marijuana in Brazil","volume":"32","author":"Carlini","year":"2010","journal-title":"Rev Bras Psiquiatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Rev Bras Psiquiatr."},{"key":"B3","author":"Mechoulam","year":"2014","journal-title":"Fluorinated CBD Compounds, Compositions and Uses Thereof"},{"key":"B4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/ja01858a058","article-title":"Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp","volume":"62","author":"Adams","year":"1940","journal-title":"J Am Chem Soc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"Hashish\u2013I: structure of cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"B7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1126\/science.169.3945.611","article-title":"Chemical basis of hashish activity","volume":"169","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF00402387","article-title":"Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa","volume":"18","author":"Carlini","year":"1970","journal-title":"Psychopharmacologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.2042-7158.1972.tb08897.x","article-title":"The content of (-) 9 -trans-tetrahydrocannabinol (9-thc) does not explain all biological activity of some Brazilian marihuana samples","volume":"24","author":"Karniol","year":"1972","journal-title":"J Pharm Pharmacol"},{"key":"B10","first-page":"379","article-title":"Composi\u00e7\u00e3o qu\u00edmica e import\u00e2ncia dos diversos constituintes na atividade farmacol\u00f3gica de amostras de Cannabis sativa Brasileiras","volume":"10","author":"Takahashi","year":"1970","journal-title":"Rev Bras Pesqui Med Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00428793","article-title":"Pharmacological interaction between cannabidiol and (-) 9 -trans-tetrahydrocannabinol","volume":"30","author":"Karniol","year":"1973","journal-title":"Psychopharmacologia"},{"key":"B12","first-page":"141","article-title":"Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination","volume":"16","author":"Zuardi","year":"1983","journal-title":"Braz J Med Biol Res."},{"key":"B13","first-page":"12","article-title":"Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats","volume":"269","author":"Zuardi","year":"1984","journal-title":"Arch Int Pharmacodyn Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00213-011-2495-x","article-title":"Interaction between cannabidiol (CBD) and Delta 9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids","volume":"219","author":"Zuardi","year":"2012","journal-title":"Psychopharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"key":"B16","first-page":"137","article-title":"Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol","volume":"249","author":"Zuardi","year":"1981","journal-title":"Arch Int Pharmacodyn Ther."},{"key":"B17","first-page":"391","article-title":"Changes in the conditioned emotional response of rats induced by 9-THC, CBD and mixture of the two cannabinoids","volume":"26","author":"Zuardi","year":"1983","journal-title":"Arq Biol TecnoI."},{"key":"B18","first-page":"25","article-title":"Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior","volume":"6","author":"Silveira","year":"1981","journal-title":"Res Commun Psychol Psychiatry Behav."},{"key":"B19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0306-3623(94)90027-2","article-title":"Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze","volume":"25","author":"Guimar\u00e3es","year":"1994","journal-title":"Gen Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fphar.2016.00493","article-title":"Bidirectional effects of cannabidiol on contextual fear memory extinction","volume":"7","author":"Song","year":"2016","journal-title":"Front Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.euroneuro.2015.02.001","article-title":"\u03b49-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption","volume":"25","author":"Stern","year":"2015","journal-title":"Eur Neuropsychopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behavior: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/fcp.12051","article-title":"Cannabidiol reverses the mCPP-induced increase in marble-burying behavior","volume":"28","author":"Nardo","year":"2014","journal-title":"Fundam Clin Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jpsychires.2012.08.012","article-title":"Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors","volume":"46","author":"Campos","year":"2012","journal-title":"J Psychiatr Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuroscience.2010.01.062","article-title":"Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience","volume":"167","author":"Campos","year":"2010","journal-title":"Neuroscience"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioral and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br J Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.pbb.2011.06.027","article-title":"Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress","volume":"99","author":"Granjeiro","year":"2011","journal-title":"Pharmacol Biochem Behav."},{"key":"B33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br J Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behav Brain Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000443890","article-title":"Prohedonic effect of cannabidiol in a rat model of depression","volume":"73","author":"Shoval","year":"2016","journal-title":"Neuropsychobiology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0269881110389095","article-title":"Cannabidiol injected into the bed nucleus of the stria terminallis reduces the expression of contextual fear conditioning via 5-HT1A receptors","volume":"26","author":"Gomes","year":"2012","journal-title":"J Psychopharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares","year":"2010","journal-title":"Behav Brain Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behav Brain Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","article-title":"Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience","volume":"24","author":"Foga\u00e7a","year":"2014","journal-title":"Eur Neuropsychopharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2015.02.023","article-title":"Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT1A receptors and stressful experiences","volume":"286","author":"Marinho","year":"2015","journal-title":"Behav Brain Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.euroneuro.2012.09.007","article-title":"Cannabidiol administration into the bed nucleus of the stria terminallis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor","volume":"23","author":"Gomes","year":"2013","journal-title":"Eur Neuropsychopharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/S1516-4446(12)70057-0","article-title":"Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug","volume":"34","author":"Schier","year":"2012","journal-title":"Rev Bras Psiquiatr."},{"key":"B47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminallis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pnpbp.2013.06.005","article-title":"Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice","volume":"46","author":"Gomes","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf."},{"key":"B51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/can.2017.0009","article-title":"A Conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans","volume":"2","author":"Nahler","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J Psychopharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(16)31702-3","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","author":"Linares","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0730-725X(00)00112-0","article-title":"Reduction of anxiety during MR imaging: a controlled trial","volume":"18","author":"Grey","year":"2000","journal-title":"Magn Reson Imaging"},{"key":"B59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by Delta9-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2009","journal-title":"Int J Neuropsychopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.2174\/13816128113199990432","article-title":"Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review","volume":"20","author":"Batalla","year":"2014","journal-title":"Curr Pharm Des."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e55821","DOI":"10.1371\/journal.pone.0055821","article-title":"Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings","volume":"8","author":"Batalla","year":"2013","journal-title":"PLoS ONE"},{"key":"B64","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2174\/1871527313666140612114838","article-title":"Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa","volume":"13","author":"de Mello Schier","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B65","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology"},{"key":"B66","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur J Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.lfs.2004.01.015","article-title":"Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum","volume":"75","author":"Guimar\u00e3es","year":"2004","journal-title":"Life Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s00213-015-3945-7","article-title":"Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine","volume":"232","author":"Pedrazzi","year":"2015","journal-title":"Psychopharmacology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"pyu041","DOI":"10.1093\/ijnp\/pyu041","article-title":"Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice","volume":"18","author":"Gomes","year":"2014","journal-title":"Int J Neuropsychopharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.schres.2016.02.004","article-title":"Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia","volume":"172","author":"Peres","year":"2016","journal-title":"Schizophr Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the treatment of psychosis in Parkinson's disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"J Psychopharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.schres.2014.11.031","article-title":"Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia","volume":"161","author":"Chaves","year":"2015","journal-title":"Schizophr Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0269881106060967","article-title":"Cannabidiol monotherapy for treatment-resistant schizophrenia","volume":"20","author":"Zuardi","year":"2006","journal-title":"J Psychopharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/S1516-44462010000100011","article-title":"Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)","volume":"32","author":"Hallak","year":"2010","journal-title":"Rev Bras Psiquiatr."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"B78","first-page":"313","article-title":"The efficacy of cannabidiol in the treatment of schizophrenia - a translational approach","volume":"37","author":"Leweke","year":"2011","journal-title":"Schizophr Bull."},{"key":"B79","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am J Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.pnpbp.2010.11.002","article-title":"The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects","volume":"35","author":"Hallak","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD)administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr Pharm Des."},{"key":"B82","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/pgmj.2004.032029","article-title":"Psychosis in Parkinson's disease","volume":"81","author":"Thanvi","year":"2005","journal-title":"Postgrad Med J."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.2174\/138161212802884681","article-title":"A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation","volume":"18","author":"Zuardi","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archgenpsychiatry.2011.161","article-title":"Induction of psychosis by \u03949-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing","volume":"69","author":"Bhattacharyya","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/npp.2011.17","article-title":"Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study","volume":"36","author":"Winton-Brown","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/S0033291711001322","article-title":"Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being","volume":"42","author":"Morgan","year":"2012","journal-title":"Psychol Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviors associated with rapid eye movement sleep behavior disorder in Parkinson's disease patients: a case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J Clin Pharm Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0269881109106925","article-title":"Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"25","author":"Valvassori","year":"2011","journal-title":"J Psychopharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1601-5215.2011.00579.x","article-title":"Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala","volume":"23","author":"R\u00e9us","year":"2011","journal-title":"Acta Neuropsychiatr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1590\/1516-4446-2012-0886","article-title":"Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain","volume":"35","author":"Valvassori","year":"2013","journal-title":"Rev Bras Psiquiatr."},{"key":"B92","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2010.06.023","article-title":"Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture","volume":"1348","author":"Cassol-Jr","year":"2010","journal-title":"Brain Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2012.09.053","article-title":"Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis","volume":"697","author":"Barichello","year":"2012","journal-title":"Eur J Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00213-011-2449-3","article-title":"Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders","volume":"219","author":"Fagherazzi","year":"2012","journal-title":"Psychopharmacology"},{"key":"B95","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12035-013-8514-7","article-title":"Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection","volume":"49","author":"da","year":"2014","journal-title":"Mol Neurobiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/appi.neuropsych.12050109","article-title":"The dynamic brain: neuroplasticity and mental health","volume":"24","author":"Kays","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1017\/S1092852916000146","article-title":"ICD and DSM: neuroplasticity and staging are still missing","volume":"21","author":"Pallanti","year":"2016","journal-title":"CNS Spectr."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.mehy.2006.09.040","article-title":"Is hippocampal atrophy a future drug target?","volume":"68","author":"Dhikav","year":"2007","journal-title":"Med Hypotheses"},{"key":"B99","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol Psychiatry"},{"key":"B100","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrn2822","article-title":"New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?","volume":"11","author":"Deng","year":"2010","journal-title":"Nat Ver Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tins.2008.01.002","article-title":"The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?","volume":"31","author":"Kempermann","year":"2008","journal-title":"Trends Neurosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.mp.4001791","article-title":"Neural stem cell proliferation is decreased in schizophrenia, but not in depression","volume":"11","author":"Reif","year":"2006","journal-title":"Mol Psychiatry"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2009.08.003","article-title":"Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action","volume":"20","author":"Lucassen","year":"2010","journal-title":"Eur Neuropsychopharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-8-12","article-title":"Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis","volume":"8","author":"Wolf","year":"2010","journal-title":"Cell Commun Signal."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e28668","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS ONE"},{"key":"B106","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2010.09.020","article-title":"Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol","volume":"114","author":"Demirakca","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"B108","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tiv.2015.11.004","article-title":"The neuroprotection of cannabidiol against MPP?-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease","volume":"30","author":"Santos","year":"2015","journal-title":"Toxicol in vitro"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e76918","DOI":"10.1371\/journal.pone.0076918","article-title":"Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect","volume":"8","author":"Solinas","year":"2013","journal-title":"PLoS ONE"},{"key":"B110","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-010-1177-4","article-title":"Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis","volume":"129","author":"McAllister","year":"2011","journal-title":"Breast Cancer Res Treat."},{"key":"B111","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","article-title":"Anxiogenic-like effects of chronic cannabidiol administration in rats","volume":"221","author":"ElBatsh","year":"2012","journal-title":"Psychopharmacology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2017.00269","article-title":"Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders","volume":"8","author":"Campos","year":"2017","journal-title":"Front Pharmacol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B114","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci Lett."},{"key":"B115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-013-9984-x","article-title":"Cannabinoid effects on \u03b2 amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro","volume":"34","author":"Janefjord","year":"2014","journal-title":"Cell Mol Neurobiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuro.2011.12.015","article-title":"Contrasting protective effects of cannabinoids against oxidative stress and amyloid-\u03b2 evoked neurotoxicity in vitro","volume":"33","author":"Harvey","year":"2012","journal-title":"Neurotoxicology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br J Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur J Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garcia-Arencibia","year":"2007","journal-title":"Brain Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/jnr.22682","article-title":"Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease","volume":"89","author":"Sagredo","year":"2011","journal-title":"J Neurosci Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1038\/cddis.2012.71","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress","volume":"3","author":"Mecha","year":"2012","journal-title":"Cell Death Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pnpbp.2016.11.005","article-title":"Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia","volume":"75","author":"Mori","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B126","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.redox.2016.12.029","article-title":"Cannabidiol attenuates OGD\/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons","volume":"11","author":"Sun","year":"2017","journal-title":"Redox Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br J Pharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/j.1476-5381.2010.01179.x","article-title":"Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice","volume":"162","author":"Avraham","year":"2011","journal-title":"Br J Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12264-015-1548-2","article-title":"Molecular network of neuronal autophagy in the pathophysiology and treatment of depression","volume":"31","author":"Jia","year":"2015","journal-title":"Neurosci Bull."},{"key":"B131","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12031-015-0703-6","article-title":"Cannabidiol post-treatment alleviates rat epileptic-related behaviors and activates hippocampal cell autophagy pathway along with antioxidant defense in chronic phase of pilocarpine-induced seizure","volume":"58","author":"Hosseinzadeh","year":"2016","journal-title":"J Mol Neurosci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.2042-7158.1973.tb10660.x","article-title":"Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents","volume":"25","author":"Carlini","year":"1973","journal-title":"J Pharm Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF00413961","article-title":"Effect of cannabidiol and other Cannabis sativa compounds on hippocampal seizures discharges","volume":"28","author":"Izquierdo","year":"1973","journal-title":"Psychopharmacologia"},{"key":"B134","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fphar.2017.00131","article-title":"Protective effects of Cannabidiol against seizures and neuronal death in a rat model of mesial temporal lobe epilepsy","volume":"8","author":"Do","year":"2017","journal-title":"Front Pharmacol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fphar.2016.00359","article-title":"\u03949-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol","volume":"7","author":"Crippa","year":"2016","journal-title":"Front Pharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"J Psychopharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7517-9-7","article-title":"Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature","volume":"9","author":"Crippa","year":"2012","journal-title":"Harm Reduct J."},{"key":"B143","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jcpt.12018","article-title":"Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report","volume":"38","author":"Crippa","year":"2013","journal-title":"J Clin Pharm Ther."},{"key":"B144","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuro.2015.08.007","article-title":"Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release","volume":"50","author":"Gobira","year":"2015","journal-title":"Neurotoxicology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0269881108096521","article-title":"Cannabidiol was ineffective for manic episode of bipolar affective disorder","volume":"24","author":"Zuardi","year":"2010","journal-title":"J Psychopharmacol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1590\/S1516-44462010000100016","article-title":"National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health","volume":"32","author":"Hallak","year":"2010","journal-title":"Rev Bras Psiquiatr."},{"key":"B147","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12035-014-8843-1","article-title":"Cannabidiol exposure during neuronal differentiation sensitizes cells against redox-active neurotoxins","volume":"52","author":"Sch\u00f6nhofen","year":"2015","journal-title":"Mol Neurobiol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"538670","DOI":"10.1155\/2015\/538670","article-title":"Evaluation of serum cytokines levels and the role of cannabidiol treatment in animal model of asthma","volume":"2015","author":"Vuolo","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B149","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2011.12.043","article-title":"Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor","volume":"678","author":"Ribeiro","year":"2012","journal-title":"Eur J Pharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/0269881112474524","article-title":"Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats","volume":"27","author":"Chagas","year":"2013","journal-title":"J Psychopharmacol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e7132","DOI":"10.1590\/1414-431x20177132","article-title":"Maternal administration of cannabidiol promotes aN anti-inflammatory effect on the intestinal wall in a gastroschisis rat model","volume":"51","author":"Callejas","year":"2018","journal-title":"Braz J Med Biol Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fphar.2018.00482","article-title":"Cannabidiol as a promising strategy to treat and prevent movement disorders?","volume":"9","author":"Peres","year":"2018","journal-title":"Front Pharmacol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pbb.2015.06.008","article-title":"Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)","volume":"135","author":"Nazario","year":"2015","journal-title":"Pharmacol Biochem Behav."},{"key":"B154","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2014.00010","article-title":"Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain","volume":"5","author":"Levin","year":"2014","journal-title":"Front Pharmacol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881113493363","article-title":"The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)","volume":"27","author":"Twardowschy","year":"2013","journal-title":"J Psychopharmacol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B157","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/08923973.2014.976794","article-title":"Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury","volume":"37","author":"Ribeiro","year":"2015","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e0158779","DOI":"10.1371\/journal.pone.0158779","article-title":"Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects","volume":"11","author":"Breuer","year":"2016","journal-title":"PLoS ONE"},{"key":"B159","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pnpbp.2017.07.012","article-title":"Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative","volume":"79","author":"Silva","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B160","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.yebeh.2016.11.021","article-title":"The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S.","volume":"70","author":"Mead","year":"2017","journal-title":"law. Epilepsy Behav."},{"key":"B161","year":"","journal-title":"A Double Blind, Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epileptic Crisis in Children and Adolescents."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02009\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T10:55:45Z","timestamp":1537527345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02009\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":161,"alternative-id":["10.3389\/fimmu.2018.02009"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02009","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"article-number":"2009"}}